Filana Therapeutics, Inc.

Market Cap

$72M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$1.32-$0.77 (-36.84%)

Jun 5, 2026

52W High $4.6452W Low $1.18

Company Details

Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzhei...

CEO

—

IPO Date

Jul 14, 2000

Website

www.filanatx.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$78M

EPS (Diluted)

Free Cash Flow

-$30M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q2 2026

Aug 13, 2026

PENDING

Q1 2026

May 7, 2026

FY 2025

Mar 12, 2026

Q4 2025

Mar 12, 2026

Q3 2025

Nov 12, 2025

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee